Related Experiment Video
Updated: May 21, 2026
08:44
Assembly and Characterization of Polyelectrolyte Complex Micelles
Published on: March 2, 2020
Polymeric conjugates for drug delivery
Nate Larson1, Hamidreza Ghandehari
1Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah, 84108, USA.
Chemistry of Materials : a Publication of the American Chemical Society
|June 19, 2012
Summary
Polymer-drug conjugates offer advanced drug delivery. Newer biodegradable and targeted systems enhance treatment efficacy and patient outcomes.
Area of Science:
- Polymer Science
- Drug Delivery
- Biomaterials
Background:
- Polymer therapeutics have advanced, with traditional carriers like poly(ethylene glycol) (PEG) and N-(2-hydroxypropyl methacrylamide) (HPMA) copolymers used clinically.
- Functionalized polymer-drug conjugates are emerging for biodegradable, stimuli-sensitive, and targeted delivery systems.
- Multifunctional carriers combining therapeutic and diagnostic agents enable simultaneous 'see and treat' capabilities.
Purpose of the Study:
- To discuss the rational design of polymer-drug conjugates.
- To review various classes of polymer-drug conjugates under investigation.
- To present the design and synthesis chemistry of different conjugates and their applications.
Main Methods:
- Review of existing literature on polymer-drug conjugates.
- Discussion of design principles for creating advanced polymeric drug delivery systems.
- Analysis of synthesis strategies and chemical properties of various conjugate classes.
Main Results:
- Traditional carriers (PEG, HPMA) are clinically established.
- Functionalized conjugates offer enhanced properties like biodegradability and targeted delivery.
- Multifunctional conjugates provide theranostic capabilities.
Conclusions:
- Polymer-drug conjugates are evolving towards sophisticated, targeted, and stimuli-responsive systems.
- The design and synthesis of these conjugates are crucial for optimizing drug delivery and therapeutic outcomes.
- Further research into various conjugate classes holds significant potential for clinical translation.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...